Return to Trial Database

COE-03

Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic Correlative Study

Status

Study Completed

Cancer Type(s)

Study Contact

Trial Locations

All sites in which the trial COE-03 being conducted in.

No data was found